Malignant Tumors of the Middle Ear and the Mastoid Process

Abstract

Any malignant neoplastic process involving the middle ear and the mastoid process has generally been considered almost a pathologic curiosity. Moreover, the condition has been almost universally supposed to respond unfavorably to therapeutic measures. Actually, it occurs less rarely than the medical literature would lead one to believe, and if it is recognized reasonably early and is dealt with adequately, the prognosis is as satisfactory as that generally offered by cancers of the nasal accessory sinuses. LITERATUREThe literature on malignant tumors of the middle ear and the mastoid process is not extensive. The largest series of cases reported (13) is that of Thorell,1 presented with a consideration of the treatment of this condition at Radiumhemmet. Outstanding articles on this sub-

Sensorineural hearing loss caused by metastatic prostatic carcinoma: a case report

“…Only nine of these 110 patients had metastatic disease (five breast, two upper respiratory tract and two genitourinary). Figi and Hempstead (1943) suggested an incidence of malignant ear disease of three per 100 000 and Lodge et al (1955) of 0.6 per 100 000. A review of the signs and symptoms of temporal bone neoplasms in 110 patients showed the following: pain (70 per cent), otorrhoea (49 percent), deafness (41 percent), facial nerve palsy (23 per cent), tinnitus (21 per cent), bleeding (18 per cent), vertigo (8 per cent).…”

Sensorineural hearing loss caused by metastatic prostatic carcinoma: a case report

“…Only nine of these 110 patients had metastatic disease (five breast, two upper respiratory tract and two genitourinary). Figi and Hempstead (1943) suggested an incidence of malignant ear disease of three per 100 000 and Lodge et al (1955) of 0.6 per 100 000. A review of the signs and symptoms of temporal bone neoplasms in 110 patients showed the following: pain (70 per cent), otorrhoea (49 percent), deafness (41 percent), facial nerve palsy (23 per cent), tinnitus (21 per cent), bleeding (18 per cent), vertigo (8 per cent).…”

Karzinomatöse Entartung nach Radikaloperation des Ohres

“…Sie gelten als Rarität. Figi und Hcmpstcad [1] geben die Häufigkeit mit 0.003%, Peele und Hauser [2] mit 0.005% aller HNO-Paticnten an. Dabei handelt es sich bei 82% der Fälle um Platten epithelkarzinome [3].…”

Embryonal rhabdo-myosarcoma of middle ear:

“…It is, therefore, not surprising that Schall reviewing in 1935 middle ear neoplasms at the Massachusetts Eye and Ear Hospital failed to observe a single case. Davison (1966) quotes Figi and Hempstead (1943) in reviewing 48 middle ear neoplasms from the Mayo Clinic between the years 1920 to 1941 and not remarking on a case although three 'sarcomas' were reported.…”

Sensorineural hearing loss caused by metastatic prostatic carcinoma: a case report

“…Only nine of these 110 patients had metastatic disease (five breast, two upper respiratory tract and two genitourinary). Figi and Hempstead (1943) suggested an incidence of malignant ear disease of three per 100 000 and Lodge et al (1955) of 0.6 per 100 000. A review of the signs and symptoms of temporal bone neoplasms in 110 patients showed the following: pain (70 per cent), otorrhoea (49 percent), deafness (41 percent), facial nerve palsy (23 per cent), tinnitus (21 per cent), bleeding (18 per cent), vertigo (8 per cent).…”

Karzinomatöse Entartung nach Radikaloperation des Ohres

“…Sie gelten als Rarität. Figi und Hcmpstcad [1] geben die Häufigkeit mit 0.003%, Peele und Hauser [2] mit 0.005% aller HNO-Paticnten an. Dabei handelt es sich bei 82% der Fälle um Platten epithelkarzinome [3].…”

Embryonal rhabdo-myosarcoma of middle ear:

“…It is, therefore, not surprising that Schall reviewing in 1935 middle ear neoplasms at the Massachusetts Eye and Ear Hospital failed to observe a single case. Davison (1966) quotes Figi and Hempstead (1943) in reviewing 48 middle ear neoplasms from the Mayo Clinic between the years 1920 to 1941 and not remarking on a case although three 'sarcomas' were reported.…”

Sensorineural hearing loss caused by metastatic prostatic carcinoma: a case report

“…Only nine of these 110 patients had metastatic disease (five breast, two upper respiratory tract and two genitourinary). Figi and Hempstead (1943) suggested an incidence of malignant ear disease of three per 100 000 and Lodge et al (1955) of 0.6 per 100 000. A review of the signs and symptoms of temporal bone neoplasms in 110 patients showed the following: pain (70 per cent), otorrhoea (49 percent), deafness (41 percent), facial nerve palsy (23 per cent), tinnitus (21 per cent), bleeding (18 per cent), vertigo (8 per cent).…”

Karzinomatöse Entartung nach Radikaloperation des Ohres

“…Sie gelten als Rarität. Figi und Hcmpstcad [1] geben die Häufigkeit mit 0.003%, Peele und Hauser [2] mit 0.005% aller HNO-Paticnten an. Dabei handelt es sich bei 82% der Fälle um Platten epithelkarzinome [3].…”

Embryonal rhabdo-myosarcoma of middle ear:

“…It is, therefore, not surprising that Schall reviewing in 1935 middle ear neoplasms at the Massachusetts Eye and Ear Hospital failed to observe a single case. Davison (1966) quotes Figi and Hempstead (1943) in reviewing 48 middle ear neoplasms from the Mayo Clinic between the years 1920 to 1941 and not remarking on a case although three 'sarcomas' were reported.…”